Skip to search formSkip to main contentSkip to account menu

GI 262570

Known as: GI-262570, GI262570 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

farglitazar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats.
2005
2005
Novel PPARgamma agonists GI 262570, GW 7845, GW 1929, and pioglitazone decrease calcium channel function and myogenic tone in rat mesenteric arteries.
Novel non-thiazolidinedione, tyrosine-derived peroxisome proliferator-activated receptor gamma agonists, GI 262570, GW 7845, GW… 
2004
2004
A yeast two-hybrid technology-based system for the discovery of PPARgamma agonist and antagonist.
2004
2004
Regional Hemodynamic Effects of the N-(2-Benzoylphenyl)-l-tyrosine Peroxisome Proliferator-Activated Receptor-γ Ligand, GI 262570 [(S)-2-(2-Benzoylphenylamino)-3-[4-[2-(5-methyl-2-phenyl-2-oxazol-4…
This study provides novel data on the regional hemodynamic effects of the peroxisome proliferator-activated receptor-γ activator… 
2003
2003
Effects of a PPAR&ggr; Agonist, GI262570, on Renal Filtration Fraction and Nitric Oxide Level in Conscious Rats
&NA; PPAR&ggr; agonists ameliorate insulin resistance and lower blood pressure. Volume expansion/edema has been observed in… 
2000
2000
Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, improves glycemic control in type 2 diabetes mellitus patients (T2DM)
2000
2000
GI262570, a tyrosine-based PPARγ agonist, reduces triglycerides and increases HDL-C concentrations in patients with type 2 diabetes mellitus when combined with glibenclamide treatment
2000
2000
Antidiabetic efficacy of GI262570 in two rodent models of type 2 diabetes
2000
2000
Monotherapy with GI262570, a non-thiazolidinedione PPARγ agonist, reduces triglyceride and increases HDL-C in patients with type 2 diabetes
2000
2000
Discovery and in vitro characterization of the novel, tyrosine-based, non-thiazolidinedione PPARγ agonist GI262570
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)